Earnings · US stocks

CG Oncology, Inc. (CGON) earnings

CG Oncology, Inc. published its quarterly report on 2026-11-06. The stock moved +12.10% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-06
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+17.27%—
3 days+12.10%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 2 of them. The stock rose in the 3 trading days after 7 of 8 reports (average +3.46%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-06-0.64+20.95%+12.10%——
2026-08-06-0.90-40.06%+5.72%+4.42%+5.35%
2026-05-08-0.71-31.53%+4.18%-4.24%-5.99%
2026-02-27-0.51+12.57%+7.91%+20.66%+22.08%
2025-11-14-0.57-4.26%+12.69%+5.56%+3.21%
2025-08-08-0.54-20.09%+2.46%+51.54%+46.57%
2025-05-13-0.45-20.31%+0.76%+3.58%-0.56%
2025-03-28-0.48-4.35%-18.15%-11.88%-11.40%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: CGON

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.